Verisk officer plans $2.39M sale of 12,277 shares

Verisk Analytics, Inc. (VRSK) is the issuer for a proposed resale of 12,277 shares of common stock by officer Nicholas Daffan under Rule 144, with an indicated aggregate market value of $2,387,471.53.

Rhea-AI Filing Summary

Verisk Analytics, Inc. (VRSK) is the issuer for a proposed resale of 12,277 shares of common stock by officer Nicholas Daffan under Rule 144, with an indicated aggregate market value of $2,387,471.53. Verisk common shares outstanding are listed as 130,156,012. In the prior three months, Daffan sold 7,821 shares for $1,491,361.62. The new sale is expected to be executed on 08/31/2026 via a broker-assisted cashless exercise of employee stock options on NASDAQ.

Key Figures

Shares to be sold: 12,277 shares of common stock Aggregate market value of proposed sale: $2,387,471.53 Shares outstanding: 130,156,012 shares +3 more

6 metrics

Shares to be sold 12,277 shares of common stock Proposed Rule 144 sale by officer Nicholas Daffan

Aggregate market value of proposed sale $2,387,471.53 Value for 12,277 Verisk common shares to be sold

Shares outstanding 130,156,012 shares Verisk common shares outstanding as listed in the Form 144

Recent shares sold 7,821 shares Verisk common stock sold by Nicholas Daffan on 08/27/2026

Aggregate value of recent sale $1,491,361.62 Value of 7,821 Verisk common shares sold during past three months

Expected sale date 08/31/2026 Planned date for broker-assisted cashless sale of 12,277 shares

Key Terms

Rule 144, broker assisted cashless sale, Exercise of employee stock options, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

broker assisted cashless sale financial

"Broker assisted cashless sale"

Exercise of employee stock options financial

"Exercise of employee stock options"

aggregate market value financial

"Common Stock | Merrill Lynch ... | 12277 | 2387471.53"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Verisk Analytics, Inc. (VRSK)?

It discloses a proposed resale of 12,277 Verisk common shares by officer Nicholas Daffan under Rule 144, tied to the cashless exercise of employee stock options, with an indicated aggregate market value of $2,387,471.53 and an expected date of 08/31/2026.

How many Verisk (VRSK) shares are planned to be sold and when?

Officer Nicholas Daffan plans to sell 12,277 shares of Verisk common stock with an expected transaction date of 08/31/2026, in a broker-assisted cashless sale on NASDAQ following the exercise of employee stock options.

What is the aggregate market value of the Verisk (VRSK) shares covered by this Form 144?

The filing lists an aggregate market value of $2,387,471.53 for the 12,277 Verisk common shares that are proposed to be sold under Rule 144 in connection with a broker-assisted cashless exercise of employee stock options.

How many Verisk (VRSK) shares has Nicholas Daffan sold in the last three months?

Over the past three months, Nicholas Daffan sold 7,821 shares of Verisk common stock on 08/27/2026, for an aggregate market value of $1,491,361.62, as reported in the Form 144 under securities sold during the past three months.

How many Verisk (VRSK) common shares are outstanding according to this filing?

The Form 144 lists 130,156,012 Verisk common shares outstanding. This figure provides context for the size of the proposed 12,277-share Rule 144 sale relative to the total shares outstanding.

What method will be used to sell the Verisk (VRSK) shares in this Form 144?

The planned disposition method is a broker assisted cashless sale following the exercise of employee stock options, with Merrill Lynch identified in the filing and the shares listed for trading on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:14 PM EDT Accepted by SEC EDGAR 08/31/2026 - 04:13 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001803783
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Verisk Analytics, Inc.
SEC File Number	001-34480
Address of Issuer	545 WASHINGTON BOULEVARD JERSEY CITY NEW JERSEY 07310-1686
Phone	201-469-2000
Name of Person for Whose Account the Securities are To Be Sold	Daffan Nicholas
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	12277	2387471.53	130156012	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/31/2026	Exercise of employee stock options	Verisk Analytics, Inc.			12277	08/31/2026	Broker assisted cashless sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nicholas Daffan 545 WASHINGTON BOULEVARD JERSEY CITY NJ 07310-1686	Common Stock	08/27/2026	7821	1491361.62

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Nicholas Daffan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)